This study looks at how faster aspart reaches and stays in the blood after injection in Chinese people with type...
The study is a Phase 2, multicounty, multicenter, non-confirmatory, investigator- and subject masked, randomized, placebo-controlled study to evaluate the safety,...
SP2086 is a new dipeptidy1 peptidase(DPP)-4 inhibitors. This study aims to evaluate the efficacy and safety of SP2086 as monotherapy...
Investigators will be determining whether a once weekly injectable medication Bydureon versus placebo is able to reduce the development of...
The phase III trial is designed with an aim of determining the efficacy of Investigational Product TRC150094 in concurrently reducing...
The purpose of this study is to assess the effect of canagliflozin relative to placebo on glycated hemoglobin (HbA1c) after...
The purpose of this study is to assess the pioglitazone plus alogliptin plus metformin is non-inferior to dapagliflozin plus alogliptin...
The Revita® system is being investigated to assess the efficacy of DMR versus Sham on improvement in Glycemic, Hepatic and...
The purpose of this research study is to determine if rifampin, an antibiotic (a medicine that treats infections), is effective...
The study's main purpose is to asses the safety, tolerability, and effect of oral administration of RG7774 on the severity...
- Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single...
This extended access study will assess the long-term safety and tolerability of bardoxolone methyl in qualified patients with chronic kidney...
Personalized medicine methods in the management of type 1 diabetes